| Authors: |
Dorff T; Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, California, USA., Hirasawa Y; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Acoba J; University of Hawaii Cancer Center, Honolulu, Hawaii, USA., Pagano I; University of Hawaii Cancer Center, Honolulu, Hawaii, USA., Tamura D; University of Hawaii Cancer Center, Honolulu, Hawaii, USA., Pal S; Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, California, USA., Zhang M; Serimmune, Goleta, California, USA., Waitz R; Serimmune, Goleta, California, USA., Dhal A; Serimmune, Goleta, California, USA., Haynes W; Serimmune, Goleta, California, USA., Shon J; Serimmune, Goleta, California, USA., Scholz M; Prostate Oncology Specialists, Marina del Rey, California, USA., Furuya H; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA., Chan OTM; University of Hawaii Cancer Center, Honolulu, Hawaii, USA., Huang J; University of Hawaii Cancer Center, Honolulu, Hawaii, USA., Rosser C; Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA charles.rosser@cshs.org. |
